Insight, China's Pharmaceutical Industry

Company Deals

Humanwell Launches RMB250M Ruicheng Venture Fund for Health Tech

Humanwell Healthcare (Group) Co., Ltd. (SHA: 600079) announced the establishment of the Wuhan Ruicheng New...

Company Drug

iRegene’s NouvNeu004 Wins FDA Special Exemption for MSA Cell Therapy

Fineline Cube Dec 1, 2025

iRegene Therapeutics announced that the U.S. FDA granted Special Exemption status to NouvNeu004 injection, approving...

Company Deals

Proviva’s PTX-912 PD-1 IL-2 Fusion Gets USD 30M Series A+ Boost

Fineline Cube Dec 1, 2025

Proviva Therapeutics announced the completion of a Series A+ financing round, raising over USD 30 million led...

Company Drug

Pfizer-Astellas’ PADCEV Wins FDA Approval for Perioperative Bladder Cancer

Fineline Cube Nov 29, 2025

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TYO: 4503) announced that the U.S. Food...

Company Drug

GenSci’s GenSci142 Wins NMPA Nod for Bacterial Vaginosis Clinical Trials

Fineline Cube Nov 29, 2025

Changchun High & New Technology Industries (Group) Inc. (SHE: 000661) announced that its subsidiary GenSci...

Company Drug

Jiuzhou Pharmaceutical Wins Tentative FDA Approval for Generic Janumet XR

Fineline Cube Nov 28, 2025

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (SHA: 603456) announced that its Abbreviated New Drug Application (ANDA)...

Company Drug

Hengrui’s Ivarmacitinib Wins NMPA Nod for Vitiligo Clinical Trials

Fineline Cube Nov 28, 2025

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276, HKG: 1276) announced that Ivarmacitinib Tablets and SHR0302...

Company Drug

Juventas CAR-T Wins Second China Approval for Lymphoma, Expands Hematology Franchise

Fineline Cube Nov 28, 2025

Juventas Cell Therapy Ltd. announced that inaticabtagene autoleucel (CNCT 19), China’s first self‑developed CD19‑targeting CAR‑T...

Company Drug

Innovent’s Picankibart Wins NMPA Approval for Psoriasis as IL-23p19 Inhibitor

Fineline Cube Nov 28, 2025

Innovent Biologics, Inc. (HKG: 1801) announced that Picankibart Monoclonal Antibody Injection (IBI112), branded XINMEIYUE, received...

Company Deals

Trulive Medical Closes Series C, Raising Over RMB 100M for Cardiovascular Innovation

Fineline Cube Nov 28, 2025

Jiangsu Trulive Medical announced the completion of a Series C financing round raising over RMB...

Company Drug

Boan Biotech’s Boyoujing Aflibercept Wins NMPA Approval for Retinal Diseases

Fineline Cube Nov 27, 2025

Shandong Boan Biotechnology Co., Ltd. (HKG: 6955) announced that its self‑developed Aflibercept Intravitreal Injection (Boyoujing)...

Company Deals

Sprint-Bioscience Sells TREX1 Program to Gilead for $14M Upfront

Fineline Cube Nov 27, 2025

Sprint Bioscience AB announced the sale of its TREX1 cancer program to Gilead Sciences, Inc....

Company Drug

Novo Nordisk’s Semaglutide 7.2 mg sNDA Submitted for Weight Management

Fineline Cube Nov 27, 2025

Novo Nordisk A/S (NYSE: NVO) announced the submission of a supplemental New Drug Application (sNDA)...

Company Drug

CSPC’s JMT206 Wins NMPA Nod for ActRII-Targeted Weight Management

Fineline Cube Nov 27, 2025

CSPC Pharmaceutical Group Limited (HKG: 1093) announced that its self‑developed recombinant fully human anti‑ActRIIA/IIB monoclonal...

Company Medical Device

MicroTech’s LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring

Fineline Cube Nov 27, 2025

MicroTech Medical (Hangzhou) Co., Ltd. (HKG: 2235) announced that its LinX Continuous Glucose Monitoring (CGM)...

Medical Device

Bio-heart’s IberiRDN Wins New Zealand Nod as Only Dual-Approach Renal Denervation System

Fineline Cube Nov 27, 2025

Shanghai Bio-heart Biological Technology Co., Ltd. (HKG: 2185) announced that its Iberis Multi-Electrode Renal Denervation...

Company Drug

IASO-Bio’s Fucaso Wins Hong-Kong Approval as First China CAR-T

Fineline Cube Nov 27, 2025

IASO Biotherapeutics announced that Fucaso (equecabtagene autoleucel injection), its proprietary fully human BCMA‑targeted CAR‑T cell...

Company Drug

BeOne’s Sotoclax Wins FDA Priority Review for Mantle Cell Lymphoma

Fineline Cube Nov 27, 2025

BeOne Medicines Ltd. (NASDAQ: ONC, HKG: 6160, SHA: 688235) announced that the U.S. FDA has accepted its...

Company Deals

Patronus Biotech Gates Foundation Grant Accelerates Malaria Vaccine Development

Fineline Cube Nov 27, 2025

Patronus Biotech Pte. Ltd. announced it has received a grant from the Gates Foundation to...

Company Deals

Innova Therapeutics Acquires Enci Therapeutics’ IVT-8086 Cancer Program

Fineline Cube Nov 27, 2025

Innova Therapeutics announced the acquisition of Enci Therapeutics, gaining its primary cancer therapeutic program IVT‑8086,...

Insight, China's Pharmaceutical Industry

Thermo Fisher Scientific to Divest Microbiology Business to Astorg for $1.075 Billion – Strategic Portfolio Optimization

Aureka Biotechnologies Secures $35M Series A+ Financing to Advance AuraIDE Platform for Functional Antibody Design

Hangzhou’s Adcoris Licenses First-in-Class 5T4-Targeting ADC ACR246 to U.S. Biotech K2 Therapeutics in Deal Worth Up to $730 Million

Sino Biopharmaceutical’s Chia Tai Tianqing and Shanghai Reunion Partner to Commercialize Respacio Hydrogel for Cervical Cancer Radiotherapy Protection in China

Beijing QL Biopharma Files HKEX IPO Prospectus with Diversified GLP-1 Portfolio Targeting Global Obesity and Metabolic Disease Markets

AbbVie Submits FDA Filing for Skyrizi Subcutaneous Induction Therapy in Crohn’s Disease – Expanding IL-23 Inhibitor Franchise

GSK’s Efimosfermin Receives Dual Regulatory Designations for MASH Treatment – Breakthrough Therapy and PRIME Status Support Phase III Development

Humanwell Launches RMB250M Ruicheng Venture Fund for Health Tech

iRegene’s NouvNeu004 Wins FDA Special Exemption for MSA Cell Therapy

Proviva’s PTX-912 PD-1 IL-2 Fusion Gets USD 30M Series A+ Boost

Pfizer-Astellas’ PADCEV Wins FDA Approval for Perioperative Bladder Cancer

GenSci’s GenSci142 Wins NMPA Nod for Bacterial Vaginosis Clinical Trials

Jiuzhou Pharmaceutical Wins Tentative FDA Approval for Generic Janumet XR

Hengrui’s Ivarmacitinib Wins NMPA Nod for Vitiligo Clinical Trials

Juventas CAR-T Wins Second China Approval for Lymphoma, Expands Hematology Franchise

Innovent’s Picankibart Wins NMPA Approval for Psoriasis as IL-23p19 Inhibitor

Trulive Medical Closes Series C, Raising Over RMB 100M for Cardiovascular Innovation

Boan Biotech’s Boyoujing Aflibercept Wins NMPA Approval for Retinal Diseases

Sprint-Bioscience Sells TREX1 Program to Gilead for $14M Upfront

Novo Nordisk’s Semaglutide 7.2 mg sNDA Submitted for Weight Management

CSPC’s JMT206 Wins NMPA Nod for ActRII-Targeted Weight Management

MicroTech’s LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring

Bio-heart’s IberiRDN Wins New Zealand Nod as Only Dual-Approach Renal Denervation System

IASO-Bio’s Fucaso Wins Hong-Kong Approval as First China CAR-T

BeOne’s Sotoclax Wins FDA Priority Review for Mantle Cell Lymphoma

Patronus Biotech Gates Foundation Grant Accelerates Malaria Vaccine Development

Innova Therapeutics Acquires Enci Therapeutics’ IVT-8086 Cancer Program

You Missed

AbbVie Submits FDA Filing for Skyrizi Subcutaneous Induction Therapy in Crohn’s Disease – Expanding IL-23 Inhibitor Franchise

GSK’s Efimosfermin Receives Dual Regulatory Designations for MASH Treatment – Breakthrough Therapy and PRIME Status Support Phase III Development

Prothena’s Coramitug Receives FDA Fast Track Designation for ATTR-CM – Advancing Novo Nordisk’s $1.2B Amyloidosis Pipeline

Jecho Biopharmaceuticals Secures FDA Clearance for JLM019 Clinical Study in Advanced Malignant Tumors – Novel Bispecific Fc Fusion Protein Targets “Cold Tumors”